Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2010
09/28/2010CA2453881C 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
09/28/2010CA2450915C Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
09/28/2010CA2449952C Medicinal composition
09/28/2010CA2407633C Method and compositions for inhibiting arteriosclerosis
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2382631C Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
09/28/2010CA2382247C Azaindoles having serotonin receptor affinity
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/23/2010WO2010107115A1 Glycine transporter inhibitor
09/23/2010WO2010107081A1 Solid preparation stably preserved in packaging
09/23/2010WO2010107069A1 Amino acid-containing ophthalmic composition
09/23/2010WO2010107040A1 Solid preparation containing npy y5 receptor antagonist
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106904A1 Hair growing and nourishing agent, hair growing and nourishing composition, and nt-4 expression inhibitor
09/23/2010WO2010072774A3 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal
09/23/2010US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240774 Use of hydrophobin polypeptides as penetration enhancers
09/23/2010US20100240773 Multifunctional linkers
09/23/2010US20100240769 Olive waste recovery
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240733 Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
09/23/2010US20100240730 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
09/23/2010US20100240713 Aromatic and heteroaromatic compounds useful in treating iron disorders
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240667 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010US20100240662 Reverse-turn mimetics and method relating thereto
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240608 particle stabilised oil-in-water emulsion
09/23/2010US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity
09/23/2010US20100239697 Abelmoschus manihot medicus flower perfumed product
09/23/2010US20100239684 Granular jelly beverage for medication and process for producing the same
09/23/2010US20100239683 Sustained release of microcrystalline peptide suspensions
09/23/2010US20100239675 Plasmon mediated photoinduced synthesis of silver triangular bipyramids
09/23/2010US20100239668 Segmented pharmaceutical dosage forms
09/23/2010US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
09/23/2010US20100239648 Self-locating, multiple application, and multiple location medical patch systems and methods therefor
09/23/2010US20100239635 Drug delivery medical device
09/23/2010US20100239616 Controlled activation ingestible identifier
09/23/2010US20100239582 Dual Specificity Antibody Fusions
09/23/2010US20100239563 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases
09/23/2010US20100239542 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
09/23/2010US20100239535 Method for isolating homogeneous populations of transduced progenitors stably expressing specific levels of a transgene
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239529 PEG-Interferon-Beta Formulations
09/23/2010US20100239518 Ophthalmic composition
09/23/2010CA2755697A1 Amide derivative
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230238A2 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
09/22/2010EP2229945A1 Combinations comprising a 4-isoquinolone derivative and anti-HIV agents
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229939A1 Capsule formulation
09/22/2010EP1436313B1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/22/2010EP1401853B1 Modulators of pharmacological agents
09/22/2010EP1371663B1 Anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
09/22/2010EP1194449B1 Inhibitors of memapsin 2 and use thereof
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN1813782B Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof
09/22/2010CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis
09/22/2010CN1545422B Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
09/22/2010CN101842486A Immunology treatment for biofilms
09/22/2010CN101842355A Substituted n-aryl pyridinones as fibrotic inhibitors
09/22/2010CN101842113A Immune response inducer
09/22/2010CN101842094A Anti-fatigue agent comprising amino acid composition
09/22/2010CN101842093A PAI-1 production inhibitor
09/22/2010CN101838266A Citric acid tropisetron raw material medicine and preparation technology of raw material medicine and injection liquid
09/22/2010CN101838263A Benzimidazole derivative with cardiovascular activity and preparing method and application thereof
09/22/2010CN101838253A Preparation method of ligustilide and butylidene phthalide
09/22/2010CN101838241A Production method of cimetidine
09/22/2010CN101837140A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837139A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837138A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837137A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837136A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837135A Pasteurisation process for microbial cells and microbial oil
09/22/2010CN101837120A Method for orally administering parathyroid hormone (PTH)
09/22/2010CN101837056A Foot-bath effervescent tablet for improving blood stasis-type thoracic obstruction caused by qi deficiency
09/22/2010CN101836978A Solid preparation containing single crystal form
09/22/2010CN101836976A Application of icaritin in preparation of anti-angiogenic medicaments
09/22/2010CN101836975A Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799833 System and method for the pretreatment of the endplates of an intervertebral disc
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
09/21/2010US7799329 Viruses for the treatment of cellular proliferative disorders
09/21/2010CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
09/21/2010CA2481229C Substituted pyrazine inhibitors of akt
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2451915C Crystalline composition containing escitalopram
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 1564